{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:37:03Z","timestamp":1793230623502,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/sla.0b013e3181f1939d","type":"journal-article","created":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T22:14:29Z","timestamp":1290550469000},"page":"1044-1051","source":"Crossref","is-referenced-by-count":125,"title":["B7\u2013H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis"],"prefix":"10.1097","volume":"252","author":[{"given":"Takaaki","family":"Arigami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhda","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando E.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave S. B.","family":"Hoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-21-20210203","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1200\/JCO.2007.15.5630","article-title":"Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011.","volume":"26","author":"Olson","year":"2008","journal-title":"J Clin Oncol"},{"key":"R3-21-20210203","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2007.13.0179","article-title":"Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized his-tologic criteria and image-based training.","volume":"26","author":"Turner","year":"2008","journal-title":"J Clin Oncol"},{"key":"R4-21-20210203","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/85339","article-title":"B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.","volume":"2","author":"Chapoval","year":"2001","journal-title":"Nat Immunol"},{"key":"R5-21-20210203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/CJI.0b013e31802e085a","article-title":"The new B7s: playing a pivotal role in tumor immunity.","volume":"30","author":"Flies","year":"2007","journal-title":"J Immunother"},{"key":"R6-21-20210203","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited.","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R8-21-20210203","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"key":"R9-21-20210203","doi-asserted-by":"crossref","first-page":"12640","DOI":"10.1073\/pnas.0405025101","article-title":"Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.","volume":"101","author":"Castriconi","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R10-21-20210203","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ni967","article-title":"The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses.","volume":"4","author":"Suh","year":"2003","journal-title":"Nat Immunol"},{"key":"R11-21-20210203","doi-asserted-by":"crossref","first-page":"10495","DOI":"10.1073\/pnas.0802423105","article-title":"Triggering receptor expressed on myeloid cell-like transcript 2 TLT-2 is a counter-receptor for B7-H3 and enhances T cell responses.","volume":"105","author":"Hashiguchi","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12-21-20210203","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1158\/0008-5472.CAN-07-1068","article-title":"B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.","volume":"67","author":"Roth","year":"2007","journal-title":"Cancer Res"},{"key":"R13-21-20210203","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lungcan.2006.05.012","article-title":"B7-H3 and B7-H4 expression in non-small-cell lung cancer.","volume":"53","author":"Sun","year":"2006","journal-title":"Lung Cancer"},{"key":"R14-21-20210203","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1158\/1078-0432.CCR-07-0419","article-title":"Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.","volume":"13","author":"Nakagawa","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R16-21-20210203","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1200\/JCO.2004.12.009","article-title":"Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients.","volume":"22","author":"Takeuchi","year":"2004","journal-title":"J Clin Oncol"},{"key":"R17-21-20210203","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/1078-0432.CCR-05-1847","article-title":"Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.","volume":"12","author":"Koyanagi","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R18-21-20210203","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/0008-5472.CAN-05-2505","article-title":"A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy.","volume":"66","author":"Goto","year":"2006","journal-title":"Cancer Res"},{"key":"R19-21-20210203","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1200\/JCO.2005.07.078","article-title":"Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.","volume":"23","author":"Kim","year":"2005","journal-title":"J Clin Oncol"},{"key":"R20-21-20210203","first-page":"441","article-title":"Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas.","volume":"63","author":"Takeuchi","year":"2003","journal-title":"Cancer Res"},{"key":"R21-21-20210203","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1200\/JCO.2005.02.0958","article-title":"Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.","volume":"23","author":"Koyanagi","year":"2005","journal-title":"J Clin Oncol"},{"key":"R22-21-20210203","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting recommendations for tumor marker prognostic studies REMARK.","volume":"97","author":"McShane","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R24-21-20210203","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri1349","article-title":"Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.","volume":"4","author":"Chen","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R25-21-20210203","doi-asserted-by":"crossref","first-page":"17174","DOI":"10.1073\/pnas.0406351101","article-title":"Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target.","volume":"101","author":"Thompson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R26-21-20210203","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1158\/0008-5472.CAN-05-1681","article-title":"Low surface expression of B7-1 CD80 is an immunoescape mechanism of colon carcinoma.","volume":"66","author":"Tirapu","year":"2006","journal-title":"Cancer Res"},{"key":"R27-21-20210203","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0888-7543(03)00126-5","article-title":"Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss.","volume":"82","author":"Ling","year":"2003","journal-title":"Genomics"},{"key":"R28-21-20210203","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.4049\/jimmunol.173.4.2500","article-title":"Murine B7-H3 is a negative regulator of T cells.","volume":"173","author":"Prasad","year":"2004","journal-title":"J Immunol"},{"key":"R29-21-20210203","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1158\/1078-0432.CCR-08-0536","article-title":"Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.","volume":"14","author":"Crispen","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R30-21-20210203","first-page":"1740","article-title":"Variations in functional immunocompe-tence of individual tumor-draining lymph nodes in humans.","volume":"47","author":"Hoon","year":"1987","journal-title":"Cancer Res"},{"key":"R31-21-20210203","first-page":"1529","article-title":"Suppressor cell activity in melanoma-draining lymph nodes.","volume":"47","author":"Hoon","year":"1987","journal-title":"Cancer Res"},{"key":"R32-21-20210203","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/328267a0","article-title":"A new member of the immunoglob-ulin super family-CTLA-4.","volume":"328","author":"Brunet","year":"1987","journal-title":"Nature"},{"key":"R33-21-20210203","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.174.3.561","article-title":"CTLA-4 is a second receptor for the B cell activation antigen B7.","volume":"174","author":"Linsley","year":"1991","journal-title":"J Exp Med"},{"key":"R34-21-20210203","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1126\/science.7694363","article-title":"Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.","volume":"262","author":"Freeman","year":"1993","journal-title":"Science"},{"key":"R35-21-20210203","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/366076a0","article-title":"B70 antigen is a second ligand for CTLA-4 and CD28.","volume":"366","author":"Azuma","year":"1993","journal-title":"Nature"},{"key":"R36-21-20210203","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.270.5238.985","article-title":"Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.","volume":"270","author":"Waterhouse","year":"1995","journal-title":"Science"},{"key":"R37-21-20210203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","article-title":"Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.","volume":"3","author":"Tivol","year":"1995","journal-title":"Immunity"},{"key":"R38-21-20210203","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1073\/pnas.0830997100","article-title":"Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients.","volume":"100","author":"Hodi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R39-21-20210203","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1200\/JCO.2005.01.109","article-title":"Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.","volume":"23","author":"Ribas","year":"2005","journal-title":"J Clin Oncol"},{"key":"R40-21-20210203","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1200\/JCO.2005.04.5716","article-title":"Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.","volume":"24","author":"Beck","year":"2006","journal-title":"J Clin Oncol"},{"key":"R41-21-20210203","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1158\/1078-0432.CCR-06-1974","article-title":"A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy.","volume":"13","author":"OMahony","year":"2007","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000658-201012000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:40:52Z","timestamp":1786041652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000658-201012000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0b013e3181f1939d","relation":{},"ISSN":["0003-4932"],"issn-type":[{"value":"0003-4932","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}